Novel antisense drug shows promise in slowing fatty liver disease
Tuesday, June 16, 2020 - 18:00
in Health & Medicine
A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.